Helen Christopher, a mom of two in England, put off seeing a doctor for pain in her right breast because she feared being judged for breastfeeding her 3-year-old son. She later learned she had stage 3 ...

Immutep's ASX-listed stock fell more than 88% on the news that its phase 3 trial TACTI-004 of LAG-3 inhibitor eftilagimod alfa (efti) as a first-line treatment for non-small cell lung cancer (NSCLC) ...

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

There has been a 'significant' rise in throat cancers among men and doctors think they know the reason as to why.

The health condition can cause throat or oropharyngeal cancer in high-risk cases, though many of the symptoms which indicate ...

People in the most socioeconomically deprived areas of the UK are more likely to die from head and neck cancer, more likely to be diagnosed at ...

As colorectal cancer rates rise in patients under 50, at least two local health systems are hiring more doctors, realigning care and increasing education.

An "under-prioritised" cancer with "persistently poor survival" rates hits the poorer communities of the North worse than the rest of the country. A new report has highlighted "wide inequalities" ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

Chloe was diagnosed with cancer shortly after turning 21, having been assured by her doctor it was just a bout of tonsillitis. It's been three years since Brit was told she had Hodgkin Lymphoma, after ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...